December 3, 2022
Loading...
You are here:  Home  >  'Cure Pharmaceutical'
Latest

Revenue and losses both up at Cure Pharmaceutical

By   /  Tuesday, September 6th, 2022  /  Banking & Finance, Earnings, Latest news, Regions, Tri-County Public Companies, Ventura County  /  Comments Off on Revenue and losses both up at Cure Pharmaceutical

Oxnard-based Cure Pharmaceutical, a drug delivery platform and CBD products company, reported more losses but rising revenue in its second quarter earnings. Cure suffered a net loss of $9.6 million in the second quarter of 2022, up substantially from a net loss of $1.3 million in the same quarter a year ago. That equates to Read More →

Latest

Cure sells $20M in intellectual property, replaces CEO and CFO

By   /  Monday, August 1st, 2022  /  Banking & Finance, Health Care & Life Science, Latest news, Regions, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Cure sells $20M in intellectual property, replaces CEO and CFO

Oxnard-based Cure Pharmaceutical, a drug delivery platform and CBD products company, will be selling a portion of its intellectual property and related assets for $20 million, the company announced July 28. The buyer was a company called TF Tech Ventures, and the deal closed July 22, Cure said in a July 28 filing with the Read More →

Latest

Losses shrink at Cure Pharmaceutical

By   /  Friday, August 20th, 2021  /  Banking & Finance, Earnings, Latest news, Tri-County Public Companies  /  Comments Off on Losses shrink at Cure Pharmaceutical

Cure Pharmaceutical Co., an Oxnard-based drug delivery product company that owns the CBD brand Sera Labs, reported rising revenue and shrinking losses for the quarter ended June 30. Cure’s net loss for the second quarter of 2021 was $1.3 million, down from a loss of $13.4 million in the same quarter of 2020. Total revenue Read More →

Latest

Cure reports net loss, rising revenue in Q1

By   /  Tuesday, May 18th, 2021  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Tri-County Economy, Tri-County Public Companies, West Ventura County  /  Comments Off on Cure reports net loss, rising revenue in Q1

Oxnard-based Cure Pharmaceutical saw another spike in revenue in the first quarter of 2021, but net losses also continued to grow. Cure had $1.5 million in revenue in the quarter ended March 31, up 400% from the first quarter of 2020, according to the company’s earnings report, released May 17. The bulk of that growth Read More →

Latest

Cure Pharmaceutical navigates CBD acquisition, licensing dispute

By   /  Friday, April 9th, 2021  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, right, Subscriber content, Top Stories, Tri-County Economy, Tri-County Public Companies, West Ventura County  /  Comments Off on Cure Pharmaceutical navigates CBD acquisition, licensing dispute

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Revenues and losses both grew at Cure in 2020

By   /  Thursday, April 1st, 2021  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Tri-County Economy, Tri-County Public Companies, West Ventura County  /  Comments Off on Revenues and losses both grew at Cure in 2020

Cure Pharmaceutical, an Oxnard company with a CBD products subsidiary, reported steep revenue growth but rising net losses in the fourth quarter and full year of 2020. In an annual statement released April 1, Cure reported revenue of $2.1 million in the final quarter of 2020, up 229% from the same quarter a year before. Read More →

Latest

Oxnard company to pursue therapeutic psychedelics

By   /  Tuesday, March 16th, 2021  /  Banking & Finance, Health Care & Life Science, Latest news, Tri-County Economy, Tri-County Public Companies, West Ventura County  /  Comments Off on Oxnard company to pursue therapeutic psychedelics

Oxnard-based Cure Pharmaceutical announced plans on March 16 to use its oral film technology to deliver LSD and other psychedelic substances to treat mental health disorders. Cure owns the CBD company Sera Labs, and Cure has used its dissolving thin film platform, Curefilm, to deliver CBD and other cannabis compounds. Cure has a license from Read More →